Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY34.89 CNY
Change Today +2.23 / 6.83%
Volume 16.3M
300016 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

beijing beilu pharmaceutic-a (300016) Snapshot

Open
CNY32.05
Previous Close
CNY32.66
Day High
CNY35.60
Day Low
CNY31.95
52 Week High
04/15/15 - CNY37.98
52 Week Low
04/28/14 - CNY8.56
Market Cap
10.9B
Average Volume 10 Days
13.5M
EPS TTM
CNY0.29
Shares Outstanding
311.3M
EX-Date
05/8/14
P/E TM
118.6x
Dividend
CNY0.10
Dividend Yield
0.29%
Current Stock Chart for BEIJING BEILU PHARMACEUTIC-A (300016)

Related News

No related news articles were found.

beijing beilu pharmaceutic-a (300016) Related Businessweek News

No Related Businessweek News Found

beijing beilu pharmaceutic-a (300016) Details

Beijing Beilu Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers oral contrast agents in magnetic resonance imaging (MRI) for abdominal check; Gadopentetate Dimeglumine injection for cranial and spinal MRI and whole body MRI; Iohexol injection for use in the blood vessels and body cavities of adults and children. The company also provides Glimepiride tablets for Type 2 diabetes mellitus, as well as an anti-anxiety product for the treatment of generalized anxiety disorder suffering from heart and spleen double deficiency syndrome. Beijing Beilu Pharmaceutical Co., Ltd. was founded in 1992 and is based in Beijing, the People’s Republic of China.

Founded in 1992

beijing beilu pharmaceutic-a (300016) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beijing beilu pharmaceutic-a (300016) Key Developments

Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter of 2015

Beijing Beilu Pharmaceutical Co., Ltd. reported earnings results for the first quarter of 2015. For the quarter, the company reported gross operating revenue of CNY 116 million, rising 47.57% from a year earlier. Net profit attributable to shareholders reached CNY 20.4302 million, hiking 28.9%.

Beijing Beilu Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Apr 15, 2015

Beijing Beilu Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Apr 15, 2015

Beijing Beilu Pharmaceutical Co., Ltd., 2014 Earnings Call, Apr 02, 2015

Beijing Beilu Pharmaceutical Co., Ltd., 2014 Earnings Call, Apr 02, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300016:CH CNY34.89 CNY +2.23

300016 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300016.
View Industry Companies
 

Industry Analysis

300016

Industry Average

Valuation 300016 Industry Range
Price/Earnings 100.0x
Price/Sales 22.8x
Price/Book 16.9x
Price/Cash Flow 119.0x
TEV/Sales 22.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEIJING BEILU PHARMACEUTIC-A, please visit www.beilu.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.